SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-18-191629
Filing Date
2018-06-13
Accepted
2018-06-13 16:08:27
Documents
4
Effectiveness Date
2018-06-13

Document Format Files

Seq Description Document Type Size
1 S-8 d604352ds8.htm S-8 52963
2 EX-5.1 d604352dex51.htm EX-5.1 4618
3 EX-10.1 d604352dex101.htm EX-10.1 120888
4 EX-23.2 d604352dex232.htm EX-23.2 1426
  Complete submission text file 0001193125-18-191629.txt   180924
Mailing Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037
Business Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037 202-734-3400
Vanda Pharmaceuticals Inc. (Filer) CIK: 0001347178 (see all company filings)

IRS No.: 030491827 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-225599 | Film No.: 18896806
SIC: 2834 Pharmaceutical Preparations